Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 30, 2015 9:11 PM ET

Healthcare Providers and Services

Company Overview of N-of-One Therapeutics, Inc.

Company Overview

N-of-One Therapeutics, Inc. provides clinical analysis, curation, and interpretation of a tumor's molecular profile to providers, diagnostic companies, individual physicians, and cancer patients. The company’s solutions include treatment strategy roadmaps, clinical trial matching, and diagnostic strategy roadmaps. Its solutions and services pivot on matching patient-specific tumor molecular profiling data with knowledge on diagnostic technologies and therapeutic options to identify relevant clinical strategies for each patient's unique cancer. The company supports oncologists by delivering content and clinical insights for cancer treatment decisions and diagnostic approaches. N-of-One Therap...

430 Bedford Street

Suite 390

Lexington, MA 02420

United States

Founded in 2007

Phone:

617-202-9808

Fax:

781-652-8220

Key Executives for N-of-One Therapeutics, Inc.

Chairman and Chief Executive Officer
Age: 63
Founder, President, Chief Medical Officer and Director
Chief Financial Officer
Vice President of Operations
Chief Technology Officer
Compensation as of Fiscal Year 2015.

N-of-One Therapeutics, Inc. Key Developments

Spectrum Health Selects N-of-One to Provide Clinical Interpretation for 50-Gene Hot-Spot Solid Tumor Panel

N-of-One, Inc. announced that it has signed an agreement with Spectrum Health to provide clinical interpretation for all cases sequenced on Spectrum Health’s 50-gene hot-spot solid tumor panel. The Spectrum Health Cancer Center is focused on delivering individualized care to each cancer patient. A commitment to high-quality care and innovation has made Spectrum Health a regional leader and a referral center for cancer treatment. N-of-One's clinical interpretation provides the relevant scientific and clinical evidence related to the mutation profile of a tumor identified by sequencing, taking into account each patient’s specific molecular profile. This in turn links the clinical and scientific evidence to therapeutic strategies relevant for each patient.

CompanionDx Selects N-of-One’s Cost-effective, High-quality Clinical Interpretation for Targeted Next-generation Sequencing Tests

N-of-One, Inc. announced that CompanionDx, a CLIA certified, high-complexity laboratory specializing in integrated genomic solutions, combining diagnostics such as next-generation sequencing, pharmacogenomics and drug monitoring, signed an agreement with N-of-One for N-of-One to provide clinical interpretation for both CompanionDx's focused and comprehensive oncology panels. Financial terms of the agreement are not disclosed. CompanionDx's next-generation sequencing evaluates the DNA in a patient's tumor via a small biopsy sample. The DNA is analyzed for key changes or somatic mutations. When combined with the company's pharmacogenomics testing, which establishes a clear understanding of the patient's potential for metabolizing a drug based on their possible germline variants, CompanionDx can help increase the efficacy of prescribed therapy creating a safer, more effective and more personalized approach to cancer treatment.

CellNetix Pathology and Laboratories Utilizes N-of-One TrialMatch

N-of-One reported that CellNetix Pathology and Laboratories has adopted N-of-One's new clinical trial matching solution, TrialMatch, as well as N-of-One clinical interpretation evidence services. Under this agreement, N-of-One will provide clinical interpretation evidence as well as molecular profile-based clinical trial matching for CellNetix next generation sequencing cancer genomics tests.

Similar Private Companies By Industry

Company Name Region
Center for Molecular Cancer Diagnostics, Inc. United States
Langsam Health Services, LLC United States
GLT Medical Services, Ltd. United States
Bound Tree Medical, LLC United States
PTRX, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact N-of-One Therapeutics, Inc., please visit www.n-of-one.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.